Clinical Trials Directory

Trials / Completed

CompletedNCT01058733

Semi-automatic Response System(SARS)in Type 2 Diabetes

Seoul St. Mary's Hospital College of Medicine The Catholic University of Korea, Seoul, Korea

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
79 (actual)
Sponsor
The Catholic University of Korea · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Accepted

Summary

Background * Various kinds of interactive online communication systems have been introduced for long-term diabetes management, and their importance in managing patients is increasing. The investigators investigated the amount of physician time needed to maintain such a system, and the investigators developed software to maximise the cost effectiveness. Methods * The investigators conducted a prospective, randomised, controlled trial to investigate the efficacy and safety of a semi-automatic response system (SARS) for online glucose monitoring over a 24-week period of patients with type 2 diabetes. In the SARS group, the "SARS" software filtered the recorded self-monitoring of blood glucose data automatically to reduce the physicians' time, and the physicians managed patients regularly but only manually in the control (manual) group. The investigators measured the time spent by the physicians for online management and compared the HbA1c levels at enrolment and follow-up.

Conditions

Interventions

TypeNameDescription
OTHERInternetnew clinical decision-supporting system for glucose monitoring, SARS, which could identify glucose data recorded by patients and make some optimal decisions.The SARS engine assigned subjects to one of three levels according to the glucose control status and glucose control method.

Timeline

Start date
2006-10-01
Primary completion
2007-05-01
Completion
2007-05-01
First posted
2010-01-29
Last updated
2010-01-29

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01058733. Inclusion in this directory is not an endorsement.